TMCnet News

Global IVD quality controls market is expected to reach USD 1,065.3 million by 2022
[November 28, 2017]

Global IVD quality controls market is expected to reach USD 1,065.3 million by 2022


LONDON, Nov. 28, 2017 /PRNewswire/ -- IVD Quality Controls Market by Product Type (Quality Controls, Data Management Software, and External Quality Assurance Services), by Application (Clinical Chemistry, Hematology, Immunoassay, Molecular Diagnostics, Microbiology, Coagulation/Hemostasis, and Others), by End User (Hospitals, Clinical/ Reference Laboratories, Research & Academic Institutes, and others), by Manufacturer Type (IVD Instrument Manufacturers and Third Party Quality Control Manufacturers)- Global Opportunity Analysis and Industry Forecast to 2022

Download the full report: https://www.reportbuyer.com/product/5219039

The rising need of faster and error free laboratory results, improving laboratory efficiency, and technological advancements in multi-analyte third party IVD quality controls are the major factors that significantly impacted the development in In Vitro Diagnostics Quality Controls Market. Global IVD quality controls market is expected to reach USD 1,065.3 million by 2022, at a CAGR of 3.8% during the forecast period of 2017 to 2022.

Following a comprehensive research on IVD quality control products and an in-depth analysis of the market scenario, the report carries out an impact analysis of the key industry drivers, restraints, trends, and opportunities listed in the market dynamics segment. Increasing number of accredited clinical laboratories, growing demand for external quality assessment (EQA) support, and increasing mandates from regulatory & accreditation bodies on the use of quality controls are the key market drivers covered in the report which will support the industry growth during the forecast period. However, additional costs burden associated with quality controls on laboratories, unfavorable reimbursement scenario for IVD tests, and lack of mandatory regulations for clinical laboratory accreditation in many emerging countries restraining the adoption of these quality control products to some extent.

The global IVD quality controls market report offers an extensive outlook of the various segments of the market. The global In Vitro Diagnostics Quality Controls Market is majorly segmented by product type (quality control products, data management software, and external quality assurance system), application (clinical chemistry, hematology, immunoassay, molecular diagnostics, microbiology, coagulation/hemostasis, and others), end user (hospitals, clinical/ reference laboratories, research and academic institutes, and others), and manufacturer type (IVD instrument manufacturers and third party quality control manufacturers); and geography (North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa).

The report further gives an extensive detail on the each segment and sub-segment covered in the report. For instance, the In Vitro Diagnostics Quality control market report briefly talks about the dynamics of the various applications of IVD quality control products. These applications include clinical chemistry, hematology, immunoassay, molecular diagnostics, microbiology, coagulation/hemostasis, and other applications. The applications segment further briefly talks about the trends impacting the growth of these markets and the benefits involved with the use of IVD quality control products in these applications to improve overall laboratory efficiency. The report also provides the market size and forecast of IVD quality control products for these application in all the countries included in the scope.




An exhaustive analysis of the geographical scenario of the industry for the six major geographies: North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa is included in the geographical analysis section. These regions are further analyzed at a country level with the detailed qualitative and quantitative analysis. The geographic analysis provides detailed insights on the key trends of the industry in the listed regions & countries, identifying the demographic & economic impact, government & private investments, and regulatory scenario. The report identifies North America to be the largest market, followed by Europe. The geographical analysis section also comments on the key market players shaping the growth of the industry in the respective countries.

The report also includes the competitive landscape based on extensive assessment of the key strategic developments adopted by leading market participants in the industry over the past 3 years (2014-2017). The study has also incorporated the market share analysis of leading players and detailed profiles of 20 top market players across the value chain of the industry, including detailed financial performance, product offerings, and strategic growth initiatives of each player.


The key players operating in the global IVD quality control market are Randox Laboratories Ltd. (U.K.), Thermo Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), Technopath Clinical Diagnostics (Ireland), SeraCare Life Sciences Inc. (U.S.), Merck KGaA (Germany), Maine Molecular Quality Controls, Inc. (U.S.), Sero AS (Norway), Eurotrol B.V. (The Netherlands), Omega Diagnostic Group PLC (U.K.), Fortress Diagnostic Limited (U.K.), Sun Diagnostics, LLC. (U.S.), Siemens AG (Germany), Abbott Laboratories (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Helena Biosciences Europe (U.K.), Danaher Corporation (U.S.), Ortho Clinical Diagnostics (U.S.), ZeptoMetrix Corporation (U.S.), and Becton Dickinson and company (U.S.).

Key questions answered in the report:

Molecular Diagnostics application to drive the adoption of IVD quality control products and services

What impact does this have on the adoption of IVD quality control products for molecular diagnostics in comparison to other applications?
Which are the high growth market segments/regions for the IVD quality control products for molecular diagnostics application?
Hospitals segment account for a large proportion of all end users of IVD quality control globally

What factors contribute to the large usage of IVD quality control products in hospitals?
Conversely, which geographic segment is expected to experience the fastest growth for hospitals segment?
The North American IVD quality control products market favors larger manufacturers that compete in multiple segments

Who are the top competitors in IVD quality controls market and what strategies do they employ to gain market shares?
What is driving growth and which market segments have the most potential for revenue expansion over the forecast period?
What strategies should new companies looking to enter IVD quality controls market use to compete effectively?
What are the major drivers, restrains, opportunities, and trends in the global IVD quality control products market?
Who are the major players in various countries and what share of the In Vitro Diagnostics Quality Controls Market do they hold?
What are the geographical trends and high growth regions/ countries in In Vitro Diagnostics Quality Controls Market?
Recent new product launches, partnerships & collaborations, approvals, and expansions taken place in the IVD quality control products space.

What companies have recently launched new products and how will these products affect the competitive landscape of the IVD quality control space?
Which companies have recently received approvals and how will these approvals promote a competitive advantage?
Who are the major players in the global In Vitro Diagnostics Quality Controls Market and what share of the market do they hold?
Who are the local emerging players in the IVD quality controls market and how do they compete with the global players?

Scope of the Report
Market by Product Type
Quality Controls
Whole blood based quality controls
Serum & Plasma based quality controls
Urine based quality controls
Other quality controls
Data Management Software
External Quality Assurance Services

Market by Application
Clinical Chemistry
Hematology
Immunoassay
Molecular Diagnostics
Microbiology
Coagulation/Hemostasis
Others

Market by End User
Hospitals
Clinical/ Reference Laboratories
Research and Academic Institutes
Others

Market by Manufacturer Type
IVD Instrument Manufacturers
Third Party Quality Control Manufacturers
Independent third party quality controls
Instrument specific third party quality controls

Market by Geography
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
Rest of Asia-Pacific
Rest of World
Latin America
Brazil
Mexico
Rest of Latin America
Middle-East
Africa

Download the full report: https://www.reportbuyer.com/product/5219039

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

View original content:http://www.prnewswire.com/news-releases/global-ivd-quality-controls-market-is-expected-to-reach-usd-10653-million-by-2022-300562748.html

SOURCE ReportBuyer


[ Back To TMCnet.com's Homepage ]